Gyre Therapeutics, Inc.
GYRE
$7.62
-$0.51-6.27%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 12.07% | 6.29% | -0.03% | -32.80% | 11.47% |
Total Receivables | -22.76% | 40.33% | 4.34% | 18.90% | -0.56% |
Inventory | 24.32% | -0.66% | 13.20% | 14.09% | 15.37% |
Prepaid Expenses | 586.38% | 13.13% | -8.85% | -35.59% | 15.71% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -5.09% | -12.14% | -9.23% | 81.53% |
Total Current Assets | 5.65% | 18.20% | 2.41% | -14.67% | 9.62% |
|
|||||
Total Current Assets | 5.65% | 18.20% | 2.41% | -14.67% | 9.62% |
Net Property, Plant & Equipment | -2.26% | -2.75% | 2.55% | 7.72% | 0.61% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 198.12% | 2.53% | 0.79% | -1.55% | -1.30% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 13.01% | -32.57% | 14.61% | 5.76% | 1.63% |
Total Assets | 3.50% | 0.13% | 3.56% | -0.89% | 4.69% |
|
|||||
Total Accounts Payable | 12.96% | -64.36% | 11.81% | -17.88% | -7.04% |
Total Accrued Expenses | 3.00% | 13.95% | -10.48% | -6.29% | -7.85% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 12.90% | 2.74% | 5.31% | 559.00% | -52.38% |
Total Finance Division Other Current Liabilities | -9.69% | 69.05% | 0.56% | -40.75% | 4.52% |
Total Other Current Liabilities | -9.69% | 69.05% | 0.56% | -40.75% | 4.52% |
Total Current Liabilities | -2.69% | 32.62% | -5.51% | -20.08% | -2.80% |
|
|||||
Total Current Liabilities | -2.69% | 32.62% | -5.51% | -20.08% | -2.80% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -11.86% | -19.62% | -15.11% | 641.14% | -12.06% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -13.42% | -39.69% | 2.21% | -21.11% | -23.80% |
Total Liabilities | -5.61% | 0.89% | -2.96% | -17.02% | -12.68% |
|
|||||
Common Stock & APIC | 1.46% | 1.41% | 0.48% | 0.34% | 95.27% |
Retained Earnings | 3.83% | -0.14% | 1.57% | 4.71% | 9.14% |
Treasury Stock & Other | 4.27% | -174.52% | 52.94% | -15.78% | -5.60% |
Total Common Equity | 7.59% | 0.22% | 4.69% | 6.55% | 457.85% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 7.59% | 0.22% | 4.69% | 6.55% | 457.85% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 3.12% | -0.60% | 6.97% | 2.69% | 7.91% |
Total Equity | 6.00% | -0.07% | 5.49% | 5.15% | 13.12% |
|